VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA” or the “Company”), a leading developer of next-generation antibody-based cancer therapies, today provided an update on its strategy and progress to implement ...

Investors are reassessing fragmented implementation models as portfolio complexity, liquidity demands, and market risks grow. A total portfolio mindset is driving greater use of overlays, completion ...

AI is top of mind for executives across every industry, with a 2023 Bloomberg report predicting that generative AI could become a $1.3 trillion market by 2032. As AI tools continue to pop up and ...

A successful AI implementation requires significant effort. Here are six challenges organizations need to address before ...

Creative Health Care Insight (CHCI) has just announced the formalization of its strategic partnership model, an expanded approach designed to help healthcare organizations build, implement and sustain ...

AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...